ReP USP - Resultado da busca

Artigo de periodico
Mesenchymal stem cells overexpressing BMP-9 by CRISPRCas9 present high in vitro osteogenic potential and enhance in vivo bone formation (2021)
Freitas, Gileade Pereira ; Lopes, Helena Bacha ; Souza, Alann Thaffarell Portilho de ; Gomes, Maria Paula Oliveira ; Quiles, Georgia Kors ; Gordon, Jonathan; Tye, Coralee; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.; Beloti, Márcio Mateus ; Rosa, Adalberto Luiz
Source: Gene Therapy. Unidade: FORP
Subjects: CÉLULAS, OSSO E OSSOS, MEDICINA REGENERATIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Gileade Pereira et al. Mesenchymal stem cells overexpressing BMP-9 by CRISPRCas9 present high in vitro osteogenic potential and enhance in vivo bone formation. Gene Therapy, v. 28, n. 12, p. 748-759, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41434-021-00248-8. Acesso em: 27 jan. 2026.
APA
Freitas, G. P., Lopes, H. B., Souza, A. T. P. de, Gomes, M. P. O., Quiles, G. K., Gordon, J., et al. (2021). Mesenchymal stem cells overexpressing BMP-9 by CRISPRCas9 present high in vitro osteogenic potential and enhance in vivo bone formation. Gene Therapy, 28( 12), 748-759. doi:10.1038/s41434-021-00248-8
NLM
Freitas GP, Lopes HB, Souza ATP de, Gomes MPO, Quiles GK, Gordon J, Tye C, Stein JL, Stein GS, Lian JB, Beloti MM, Rosa AL. Mesenchymal stem cells overexpressing BMP-9 by CRISPRCas9 present high in vitro osteogenic potential and enhance in vivo bone formation [Internet]. Gene Therapy. 2021 ; 28( 12): 748-759.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-021-00248-8
Vancouver
Freitas GP, Lopes HB, Souza ATP de, Gomes MPO, Quiles GK, Gordon J, Tye C, Stein JL, Stein GS, Lian JB, Beloti MM, Rosa AL. Mesenchymal stem cells overexpressing BMP-9 by CRISPRCas9 present high in vitro osteogenic potential and enhance in vivo bone formation [Internet]. Gene Therapy. 2021 ; 28( 12): 748-759.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-021-00248-8
Artigo de periodico
Lentiviral gene therapy rescues p47phox chronic granulomatous disease and the ability to fight Salmonella infection in mice (2020)
Schejtman, Andrea; Aragão Filho, Walmir Cutrim ; Clare, Simon ; Zinicola, Marta; Weisser, Maren; Burns, Siobhan O. ; Booth, Claire ; Gaspar, Hubert B. ; Thomas, David C.; Condino Neto, Antonio ; Thrasher, Adrian J. ; Santilli, Giorgia
Source: Gene Therapy. Unidade: ICB
Subjects: IMUNOLOGIA, SALMONELOSE ANIMAL, CAMUNDONGOS, GRANULOMA, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, INFLAMAÇÃO, MUTAÇÃO GENÉTICA, ATIVAÇÃO ENZIMÁTICA, ENZIMAS, CÉLULAS-TRONCO, GENÉTICA ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHEJTMAN, Andrea et al. Lentiviral gene therapy rescues p47phox chronic granulomatous disease and the ability to fight Salmonella infection in mice. Gene Therapy, v. 27, p. 459–469, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41434-020-0164-6. Acesso em: 27 jan. 2026.
APA
Schejtman, A., Aragão Filho, W. C., Clare, S., Zinicola, M., Weisser, M., Burns, S. O., et al. (2020). Lentiviral gene therapy rescues p47phox chronic granulomatous disease and the ability to fight Salmonella infection in mice. Gene Therapy, 27, 459–469. doi:10.1038/s41434-020-0164-6
NLM
Schejtman A, Aragão Filho WC, Clare S, Zinicola M, Weisser M, Burns SO, Booth C, Gaspar HB, Thomas DC, Condino Neto A, Thrasher AJ, Santilli G. Lentiviral gene therapy rescues p47phox chronic granulomatous disease and the ability to fight Salmonella infection in mice [Internet]. Gene Therapy. 2020 ; 27 459–469.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-020-0164-6
Vancouver
Schejtman A, Aragão Filho WC, Clare S, Zinicola M, Weisser M, Burns SO, Booth C, Gaspar HB, Thomas DC, Condino Neto A, Thrasher AJ, Santilli G. Lentiviral gene therapy rescues p47phox chronic granulomatous disease and the ability to fight Salmonella infection in mice [Internet]. Gene Therapy. 2020 ; 27 459–469.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-020-0164-6
Artigo de periodico
Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth (2020)
Tamura, Rodrigo Esaki ; Lana, Marlous Vinicius Gomes; Costanzi-Strauss, Eugenia ; Strauss, Bryan Eric
Source: Gene Therapy. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, NEOPLASIAS PROSTÁTICAS, QUIMIOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, LEUCOPENIA ANIMAL, CAMUNDONGOS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMURA, Rodrigo Esaki et al. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41434-019-0071-x. Acesso em: 27 jan. 2026.
APA
Tamura, R. E., Lana, M. V. G., Costanzi-Strauss, E., & Strauss, B. E. (2020). Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy. doi:10.1038/s41434-019-0071-x
NLM
Tamura RE, Lana MVG, Costanzi-Strauss E, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-019-0071-x
Vancouver
Tamura RE, Lana MVG, Costanzi-Strauss E, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-019-0071-x
Artigo de periodico-apres/intr
Mesenchymal stem cells as new perspective for the treatment of alcohol use disorder (2020)
Camarini, Rosana
Source: Gene Therapy. Unidade: ICB
Subjects: FARMACOLOGIA, ALCOOLISMO, TRANSTORNOS RELACIONADOS AO USO DE ÁLCOOL, CÉLULAS-TRONCO, MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMARINI, Rosana. Mesenchymal stem cells as new perspective for the treatment of alcohol use disorder. Gene Therapy. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41434-020-0133-0. Acesso em: 27 jan. 2026. , 2020
APA
Camarini, R. (2020). Mesenchymal stem cells as new perspective for the treatment of alcohol use disorder. Gene Therapy. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1038/s41434-020-0133-0
NLM
Camarini R. Mesenchymal stem cells as new perspective for the treatment of alcohol use disorder [Internet]. Gene Therapy. 2020 ; 27( 10-11): 471-473.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-020-0133-0
Vancouver
Camarini R. Mesenchymal stem cells as new perspective for the treatment of alcohol use disorder [Internet]. Gene Therapy. 2020 ; 27( 10-11): 471-473.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/s41434-020-0133-0
Artigo de periodico
Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction (2010)
Gonçalves, G. A.; Vassallo, P. F.; Santos, L. dos; Schetter, I. T.; Nakamura, J. S.; Becker, C.; Tucci, P. J. F.; Krieger, J. E.
Source: Gene Therapy. Unidade: FM
Subjects: FIBROBLASTOS, ENDOTÉLIO VASCULAR, FATORES DE CRESCIMENTO, GENES (ANÁLISE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, G. A. et al. Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction. Gene Therapy, v. 17, p. 305-314, 2010Tradução . . Disponível em: https://doi.org/10.1038/gt.2009.146. Acesso em: 27 jan. 2026.
APA
Gonçalves, G. A., Vassallo, P. F., Santos, L. dos, Schetter, I. T., Nakamura, J. S., Becker, C., et al. (2010). Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction. Gene Therapy, 17, 305-314. doi:10.1038/gt.2009.146
NLM
Gonçalves GA, Vassallo PF, Santos L dos, Schetter IT, Nakamura JS, Becker C, Tucci PJF, Krieger JE. Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction [Internet]. Gene Therapy. 2010 ; 17 305-314.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/gt.2009.146
Vancouver
Gonçalves GA, Vassallo PF, Santos L dos, Schetter IT, Nakamura JS, Becker C, Tucci PJF, Krieger JE. Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction [Internet]. Gene Therapy. 2010 ; 17 305-314.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/gt.2009.146
Artigo de periodico
Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice (2004)
Silva, Célio Lopes; Bonato, Vânia Luiza Deperon; Coelho-Castelo, Arlete Aparecida Martins; Souza, A. O. de; Santos, S. A.; Lima, K. M.; Faccioli, Lúcia Helena; Rodrigues, J. M.
Source: Gene Therapy. Unidades: FMRP, FCFRP
Subjects: TUBERCULOSE, VACINAS, IMUNOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Célio Lopes et al. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy, 2004Tradução . . Disponível em: https://doi.org/10.1038/sj.gt.3302418. Acesso em: 27 jan. 2026.
APA
Silva, C. L., Bonato, V. L. D., Coelho-Castelo, A. A. M., Souza, A. O. de, Santos, S. A., Lima, K. M., et al. (2004). Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy. doi:10.1038/sj.gt.3302418
NLM
Silva CL, Bonato VLD, Coelho-Castelo AAM, Souza AO de, Santos SA, Lima KM, Faccioli LH, Rodrigues JM. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice [Internet]. Gene Therapy. 2004 ;[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/sj.gt.3302418
Vancouver
Silva CL, Bonato VLD, Coelho-Castelo AAM, Souza AO de, Santos SA, Lima KM, Faccioli LH, Rodrigues JM. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice [Internet]. Gene Therapy. 2004 ;[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/sj.gt.3302418
Artigo de periodico
Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis (2003)
Lima, K. M.; Santos, S. A.; Lima, V. M. F.; Coelho-Castelo, A. A. M.; Rodrigues Junior, J. M.; Silva, Célio Lopes
Source: Gene Therapy. Unidade: FMRP
Subjects: TUBERCULOSE, VACINAS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, K. M. et al. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Therapy, v. 10, p. 678-685, 2003Tradução . . Disponível em: https://doi.org/10.1038/sj.gt.3301908. Acesso em: 27 jan. 2026.
APA
Lima, K. M., Santos, S. A., Lima, V. M. F., Coelho-Castelo, A. A. M., Rodrigues Junior, J. M., & Silva, C. L. (2003). Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Therapy, 10, 678-685. doi:10.1038/sj.gt.3301908
NLM
Lima KM, Santos SA, Lima VMF, Coelho-Castelo AAM, Rodrigues Junior JM, Silva CL. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis [Internet]. Gene Therapy. 2003 ; 10 678-685.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/sj.gt.3301908
Vancouver
Lima KM, Santos SA, Lima VMF, Coelho-Castelo AAM, Rodrigues Junior JM, Silva CL. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis [Internet]. Gene Therapy. 2003 ; 10 678-685.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/sj.gt.3301908
Artigo de periodico
Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor (2003)
Novak, Estela Maria; Metzger, Martin Andreas ; Chammas, Roger; Costa, Marilene da; Dantas, Katia; Manabe, Claudia; Pires, Janina; Oliveira, Ana Carolina de; Byddlowski, Sergio Paulo
Source: Gene Therapy. Unidade: ICB
Assunto: FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOVAK, Estela Maria et al. Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Therapy, v. 10, n. 23, p. 1992-1997, 2003Tradução . . Disponível em: https://doi.org/10.1038/sj.gt.3302111. Acesso em: 27 jan. 2026.
APA
Novak, E. M., Metzger, M. A., Chammas, R., Costa, M. da, Dantas, K., Manabe, C., et al. (2003). Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor. Gene Therapy, 10( 23), 1992-1997. doi:10.1038/sj.gt.3302111
NLM
Novak EM, Metzger MA, Chammas R, Costa M da, Dantas K, Manabe C, Pires J, Oliveira AC de, Byddlowski SP. Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor [Internet]. Gene Therapy. 2003 ; 10( 23): 1992-1997.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/sj.gt.3302111
Vancouver
Novak EM, Metzger MA, Chammas R, Costa M da, Dantas K, Manabe C, Pires J, Oliveira AC de, Byddlowski SP. Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor [Internet]. Gene Therapy. 2003 ; 10( 23): 1992-1997.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1038/sj.gt.3302111

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation